Cargando…
Correction: Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma
Correction for ‘Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma’ by M. A. Rajora et al., Chem. Sci., 2017, DOI: ; 10.1039/c7sc00732a.
Autores principales: | Rajora, M. A., Ding, L., Valic, M., Jiang, W., Overchuk, M., Chen, J., Zheng, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157424/ https://www.ncbi.nlm.nih.gov/pubmed/30294416 http://dx.doi.org/10.1039/c7sc90047c |
Ejemplares similares
-
Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma
por: Rajora, M. A., et al.
Publicado: (2017) -
Porphyrins and Phthalocyanines for Theranostics
por: Lovell, Jonathan F., et al.
Publicado: (2012) -
Tailor made magnetic nanolights: fabrication to cancer theranostics applications
por: Das, Poushali, et al.
Publicado: (2021) -
Porphyrin-lipid stabilized paclitaxel nanoemulsion for combined photodynamic therapy and chemotherapy
por: Chang, Enling, et al.
Publicado: (2021) -
Silver Nanoparticles Decorated with PEGylated Porphyrins as Potential Theranostic and Sensing Agents
por: Nicosia, Angelo, et al.
Publicado: (2021)